Publication | Closed Access

Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signaling

PharmacotherapyCerebral Vascular RegulationNeuroinflammationInflammationNeuroinflammatory ResponseBrain InjuryNeurologyMapk/nf-κb SignalingNeuroimmunologyIschemic SyndromeMolecular SignalingNeuropharmacologyCerebral Ischemia/reperfusion InjuryVascular BiologyNeuroprotectionCerebral Blood FlowReperfusion InjuryPharmacologyIschemic StrokeNeuroscienceMedicine